ACT Brief: AI Leadership and Organizational Adoption, Bayesian Methods in Drug Development, and NIH Budget Reductions

In today's ACT Brief, we explore the leadership priorities that enable meaningful AI gains in clinical research, how Bayesian methodologies are reshaping trial design and innovation, and proposed federal budget cuts threatening NIH research funding.